clinical trials

News

The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.

News

A phase 3 win suggests Takeda's $300m wager on Protagonist's rusfertide for rare blood cancer polycythaemia vera (PV) appears to have paid off.

Patients

The patient experience in healthcare is often the focal point of interaction between patients and their clinicians.

News

AstraZeneca could be the first to bring an oral SERD to market in first-line breast cancer after camizestrant hit the mark in a phase 3 trial.

News

Bayer is close to filing a new MRI contrast agent that can reduce levels of gadolinium, which can have health and environmental consequences.

News

Ten out of 11 children with congenital deafness treated with a gene therapy developed by Regeneron have seen "notable" improvements in hearing.